Cardinal Health, Inc. · NYSE:CAH
Cardinal Health — Q3 FY2007 Earnings Presentation
26 slides from Cardinal Health's earnings presentation, Apr 26, 2007
Slide 1: Third Quarter Earnings
Exhibit 99.03 2007 Third Quarter Earnings April 26, 2007
Slide 2: Forward-Looking Statements and GAAP Reconciliation
Forward-Looking Statements and GAAP Reconciliation Except for historical information, all other information in this presentation consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements are subject
Slide 3: Today's Agenda
Today’s Agenda Opening remarks Kerry Clark Chief Executive Officer Financial overview Jeff Henderson Chief Financial Officer Q&A 3
Slide 4: Financial Overview
Financial Overview • FY 2007 Q3 Results – Consolidated • FY 2007 Q3 Results – Business Segments • Progress Against Key Value Drivers • FY 2007 Financial Targets and Goals • Other Items 4
Slide 5: Q3 FY 2007 Recap
Q3 FY 2007 Recap GAAP Basis Non-GAAP Basis $M % Change 1 $M % Change 1 Revenue $21,867 8% Operating earnings/(loss) $ (10) N.M. $ 606 9% Earnings/(loss) from $ (5) N.M. $ 390 10% continuing operations Diluted EPS from continuing $ (0.01) N.M. $ 0.96 16% operations Operating cash flow $ 676 Return on
Slide 6: Q3 Operating Earnings and EPS
Q3 Operating Earnings and EPS Q3 FY 2007 Q3 FY 2006 Operating Diluted EPS from Operating Diluted EPS from Earnings/(Loss) Continuing Earnings/(Loss) Continuing ($M) Operations ($M) Operations GAAP Consolidated ($10) ($0.01) $535 $0.80 Special Items $612 $0.96 $13 $0.02 Impairment Charges & Other $4
Slide 7: Cardinal Health Business Analysis: Healthcare Supply Chain Services - Pharmaceutical
Cardinal Health Business Analysis Healthcare Supply Chain Services - Pharmaceutical Q3 FY ‘07 Q3 FY ‘06 $M $M % change Revenue $ 19,246 $ 17,785 8% Segment profit $ 380 $ 329 15% Non-recurring and other items $ (2) Highlights: • Direct-store-door (DSD) pharmaceutical and bulk customer sales grew 11%
Slide 8: Cardinal Health Business Analysis: Healthcare Supply Chain Services - Medical
Cardinal Health Business Analysis Healthcare Supply Chain Services - Medical Q3 FY ‘07 Q3 FY ‘06 $M $M % change Revenue $ 1,907 $ 1,829 4% Segment profit $ 89 $ 93 (5%) Highlights: • Strong revenue growth in laboratory and Canadian operations partially offset by sales weakness in Presource and acute
Slide 9: Cardinal Health Business Analysis: Clinical Technologies and Services
Cardinal Health Business Analysis Clinical Technologies and Services Q3 FY ‘07 Q3 FY ‘06 $M $M % change Revenue $ 674 $ 603 12% Segment profit $ 98 $ 88 12% Highlights: • Strong sales of Pyxis and Alaris products; committed contracts up significantly over prior year • Demonstrated “All Meds Solution
Slide 10: Cardinal Health Business Analysis: Medical Products Manufacturing
Cardinal Health Business Analysis Medical Products Manufacturing Q3 FY ‘07 Q3 FY ‘06 $M $M % change Revenue $ 458 $ 413 11% Segment profit $ 47 $ 45 4% Highlights: • Solid top-line growth across the segment driven by special procedures products, gloves and other infection prevention products • Stron
Slide 11: Progress Against Key Value Drivers
Progress Against Key Value Drivers Drive Top-line Growth and Gross Margin Expansion • Strong customer demand and successful new offerings from CTS and MPM Focused • Improved generics customer compliance and sourcing Operating Improve Operating Efficiency Growth • Increased SG&A leverage year-to-date
Slide 12: Acquisition Scorecard
Acquisition Scorecard Acquisition Date Results Specialty Scripts (HSCS-P) January ’07 (+) Care Fusion (CTS) October ’06 (+) MedMined (CTS) July ’06 (+) Dohmen (HSCS-P) June ’06 (+) Denver Biomedical (MPM) May ’06 (+) Parmed (HSCS-P) March ’06 (+) Source Medical (HSCS-M) November ’05 (+) Geodax (HSCS
Slide 13: Outlook
Outlook Overall • Full year EPS guidance remains in $3.25 – $3.40 range¹ • Upside from use of PTS proceeds to be offset by CAH Foundation contribution of approximately $30M in Q4 Healthcare Supply • HSCS-P: Strong performance to date driven by: improved buy-side margins and generic launches Chain Se
Slide 14: FY 2007 Financial Targets & Goals
FY 2007 Financial Targets & Goals As of April 26, 2007 Long-Term Financial Goals One Year Targets Over FY'07 - FY'09 3 Year Period: Fiscal Year 2007 Revenue: + 8 - 10% In upper half of range EPS ¹: + 12 - 15% $3.25 - $3.40 per share (includes equity compensation expense) FY07 Segment Segment Profit2
Slide 15: Other Items
Other Items PTS Divestiture 8-K Updating Historical Financials – Reflects new reportable segments – PTS in discontinued operations – Allocation of equity compensation to segments 15
Slide 16: Cardinal Health
CardinalHealth
Slide 17: Cardinal Health - Working together. For life.
Se CardinalHealth Working together. For life.”
Slide 18: GAAP / Non-GAAP Reconciliation: Operating Earnings / (Loss)
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION Third Quarter 2007 Year-to-Date 2007 Impairment Impairment (in millions, except per Common Share Charges and Charges and amounts) GAAP Special Items Other Non-GAAP GAAP Special Items Other Non-GAAP Operating Earnings / (Loss) Amou
Slide 19: GAAP / Non-GAAP Reconciliation: Return on Equity and Invested Capital
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION Third Quarter Year-to-Date (in millions) 2007 2006 2007 2006 GAAP return on equity 0.9% 6.8% 16.3% 10.4% Non-GAAP Return on Equity Net earnings $ 19.0 $ 146.8 $ 1,028.9 $ 679.1 Special items, net of tax, in continuing operations 3
Slide 20: GAAP / Non-GAAP Reconciliation: Effective Tax Rate and Net Debt
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION Third Quarter Year-to-Date (in millions) 2007 2006 2007 2006 GAAP effective tax rate from continuing operations 88.2% 33.1% 29.3% 32.9% Non-GAAP Effective Tax Rate from Continuing Operations Earnings / (loss) before income taxes a
Slide 21: GAAP / Non-GAAP Reconciliation: Pharmaceutical Economic Profit Margin FY2007
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION (in millions) HEALTHCARE SUPPLY CHAIN SERVICES Pharmaceutical First Quarter Fiscal 2007 Second Quarter Fiscal 2007 Third Quarter Fiscal 2007 2007 July August September Total October November December Total January February March T
Slide 22: GAAP / Non-GAAP Reconciliation: Medical Economic Profit Margin FY2007
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION (in million) HEALTHCARE SUPPLY CHAIN SERVICES Medical First Quarter Fiscal 2007 Second Quarter Fiscal 2007 Third Quarter Fiscal 2007 2007 July August September Total October November December Total January February March Total YTD
Slide 23: GAAP / Non-GAAP Reconciliation: Pharmaceutical Economic Profit Margin FY2006
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION (in millions) HEALTHCARE SUPPLY CHAIN SERVICES Pharmaceutical First Quarter Fiscal 2006 Second Quarter Fiscal 2006 Third Quarter Fiscal 2006 Fiscal 2006 July August September Total October November December Total January February
Slide 24: GAAP / Non-GAAP Reconciliation: Medical Economic Profit Margin FY2006
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION (in millions) HEALTHCARE SUPPLY CHAIN SERVICES Medical First Quarter Fiscal 2006 Second Quarter Fiscal 2006 Third Quarter Fiscal 2006 Fiscal 2006 July August September Total October November December Total January February March T
Slide 25: GAAP / Non-GAAP Reconciliation: Operating Margin
CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION Third Quarter (in millions) 2007 GAAP operating margin (0.04)% Non-GAAP Operating Margin Operating earnings / (loss) $ (9.8) Special items 612.0 Impairment charges and other 3.6 Non-GAAP operating earnings $ 605.8 Revenue $ 21,867
Slide 26: Definitions
CARDINAL HEALTH, INC. AND SUBSIDIARIES DEFINITIONS GAAP Debt: long-term obligations plus short-term borrowings Debt to Total Capital: debt divided by (debt plus total shareholders’ equity) Diluted EPS from Continuing Operations: earnings / (loss) from continuing operations divided by diluted weighte